FIA
RVLP

FNY Investment Advisers’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

FNY Investment Advisers’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,046
Closed -$15K – 1228
2019
Q2 		$15K Buy
+4,046
New +$13.5K ﹤0.01% 533

Other funds holding RVLP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

FNY Investment Advisers's RVLP Position: Q3 2019 in Review

FNY Investment Advisers sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2019, closing a stake of 4,046 shares — an estimated $15K sold.

FNY Investment Advisers first reported a position in RVLP in Q2 2019 and held it in 1 quarter. The position peaked at $15K in Q2 2019. 40 funds tracked by Wall St. Rank hold RVLP as of Q3 2019.

  • FNY Investment Advisers reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 4,046 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2019, an estimated $15K.
  • FNY Investment Advisers first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2019 and held it in 1 quarter.
  • FNY Investment Advisers's RVL Pharmaceuticals plc Ordinary Shares position peaked at $15K in Q2 2019.
  • 40 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2019.

Based on FNY Investment Advisers's 13F filing for Q3 2019, filed 25 Oct 2019.